Tradestie Institutional Equity Comparison Engine

VIR vs ANNX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VIR Overall Edge

VIR Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vir Biotechnology, Inc. Common Stock (VIR) driven by superior Valuation, Momentum & Technical while ANNX counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, VIR trades at 4.3x Forward P/E with -70.2% operating margin (+19582.5% YoY revenue) versus ANNX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, VIR sits in BREAKDOWN (5th %ile IV; Dealer Gamma Walls on Pro) against ANNX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VIR
VIR 4.3x vs ANNX N/M Fwd P/E
Growth & Margin Winner ANNX
Op Margin -70.2% vs 0.0% ยท YoY +19582.5% vs +0.0%
Momentum & Technical Winner VIR
1Y +64.3% vs +28.0% ยท 52W Pos 43% vs 18%
Options & Structure Winner ANNX
BREAKDOWN (5th %ile IV) vs BREAKDOWN (100th %ile IV)
VIR NASDAQ
Vir Biotechnology, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$9.25
-3.44% 1D
Market Cap $1.7B
1M Return -9.4%
1Y Return +64.3%
Forward P/E 4.3x
Unified AI Score
46.2 / 100 HOLD
Tech 37.0 Fund 54.0 Flow 67.0 Mom 60.0
ANNX NASDAQ
Annexon, Inc. Common Stock
Pharmaceutical Preparations
$3.47
-2.8% 1D
Market Cap $747.8M
1M Return -13.47%
1Y Return +28.04%
Forward P/E N/M
Unified AI Score
43.5 / 100 HOLD
Tech 37.0 Fund 55.0 Flow 72.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VIR +64.3% ANNX +28.04% Spread: +36.26 pp (VIR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VIR TTM Op. Margin: -70.2% ANNX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VIR vs ANNX. Trailing 12-month operating profitability (VIR -70.2% vs ANNX 0.0%) and valuation multiples (VIR 4.3x vs ANNX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VIR (7) vs ANNX (3)
Institutional Metric VIR ANNX Criterion Row Winner
Market Capitalization Scale $1.7B $747.8M Larger Scale VIR
Trailing P/E Ratio Valuation 4.3x N/M Lower Multiple VIR
Forward P/E Ratio Valuation 4.3x N/M Lower Multiple VIR
Revenue Growth (YoY) Growth +19582.5% +0.0% Higher Growth VIR
Operating Margin (TTM) Profitability -70.2% 0.0% Higher Margin ANNX
Net Profit Margin Profitability -61.0% 0.0% Higher Margin ANNX
Return on Equity (ROE) Capital Efficiency -21.8% -130.8% Higher ROE VIR
52-Week Range Position Momentum 43% ($5โ€“$14) 18% ($3โ€“$7) Stronger Trend VIR
Beta / 30D Volatility Risk Regime 1.75ฮฒ ยท 101% Vol 1.70ฮฒ ยท 63% Vol Lower Realized Risk ANNX
Unified Institutional Score Composite Signal 46.2 / 100 (HOLD) 43.5 / 100 (HOLD) Higher Composite VIR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VIR vs ANNX Buy Guide
VIR BREAKDOWN
6d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live VIR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ANNX BREAKDOWN
88d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live ANNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VIR nor ANNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.